Aju Mathew
Cancer doc, public health & global health researcher, teacher. @UKentucky via Trivandrum, Stockholm, Cambridge and Pittsburgh. Director, Kerala Cancer Care.
Last synced from Twitter 91d ago
Is Kerala’s LDF government sharing data with Canadian PHRI in rebranded health survey?
Emails disclosed by a whistleblower reveal that LDF did little apart from rebrand and revive the UDF's KHOBS health survey as KIRAN.
White Rice Intake and Incident Diabetes: A Study of 132,373 Participants in 21 Countries
OBJECTIVE Previous prospective studies on the association of white rice intake with incident diabetes have shown contradictory results but were conducted in single countries and predominantly in Asia. We report on the association of white rice with...
Fauci admits administration has restricted his media appearances, says he's not surprised Trump got COVID
In a wide-ranging 60 Minutes interview, Dr. Anthony Fauci expresses his frustration with a Trump campaign ad; explains why, early in the pandemic, masks were largely recommended for health care workers; and says whether he plans to vote in person.
Dr. Ramesh Nigam Memorial Oration – The Association of Surgeons of India
Aju Mathew
Chanced upon a biography of a young talented surgeon who suddenly went blind just when he was launching his teaching/academic career. But he overcame the obstacles and created a lasting impression in academics for several more decades.
104d
Methodology
The African Breast Cancer - Disparities in Outcomes (ABC-DO) study is a within-Africa, multi-country study of factors that affect breast cancer outcomes for patients at public hospitals across different sub-Saharan African settings
Open Notes in Oncology: Patient versus Oncology Clinician Views
Beginning November 2, 2020, opening clinical notes to patients with cancer will no
longer be a decision left to individual clinicians or institutional preference but
rather a requirement, as a result of the 21st Century Cures Act Interoperability...
India's new paper Covid-19 test could be a ‘game changer’
The test, named after a famous Indian fictional detective, is based on gene-editing technology called Crispr.
Oncology’s “Hockey Stick” Moment for the Cost of Cancer Drugs
This Viewpoint discusses the potential consequences associated with the rising cost of anticancer drugs and proposes 3 likely responses.
India pushes bold ‘one nation, one subscription’ journal-access plan
Researchers will also recommend an open-access policy that promotes research being shared on online repositories.
The Art of Clear Writing - India Uncut
An online writing course spread out over four weeks. Registration for October batches is now open. There are few things as agonizing as having something to say – but not ... Read more
Comparison of Interval Breast Cancers Compared With Screening-Detected Breast Cancers
This population-based cohort study examines breast cancer–specific mortality rates associated with interval breast cancer compared with those of screen-detected breast cancers.
Why a Negative Test Doesn’t Guarantee You Don’t Have the Coronavirus
We want coronavirus tests to give us the all-clear. But, in medicine, test results are clues, not answers—and no test is perfect.
Aju Mathew
This must be the best article you can read about diagnosing diseases in mathematical terms (at the end of the day, mathematics rules the World; never ever thought I'd write these words) . #doctoringthoughts
128d
Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial
PURPOSE Given the poor results using hypofractionated radiotherapy for early breast cancer, a dose of 50 Gy in 25 fractions (fr) has been the standard regimen used by the Danish Breast Cancer Group (DBCG) since 1982. Results from more recent trials...
Data for doctors? - Community Health Diaries
Data is being increasingly used in the world including in the field of medicine. How do we look at Data Science and Evidence Based Medicine together
Sethuraman IPS: a zero to hero tale
The journey of Sethuraman IPS - from a shanty in Munnar to the corridors of power, is a lesson for each one of us.
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
Background Immune checkpoint inhibitors that block programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) have improved outcomes for many cancer subtypes but do exhibit toxicity, in the form of immune-related adverse...